Rock v. Rangos, 61 A.3d 239

Akustica, a Delaware corporation, faced liquidity needs and sought Series C financing led by Rangos/Mobius with MBVC later withdrawing.
Appellant James H. Rock was Akustica’s CEO and director until his August 5, 2008 termination.
Rangos Family retained substantial voting power, including board seats and blocking rights, shaping financing terms.
Term Sheet II (August 12, 2008) approved by a board that included Rangos and other conflicted members, diluting non-Rangos shareholders.
Rock asserted direct action for equity dilution under Gentile v. Rossette despite not owning a controlling stake after Bosch acquisition.
Trial court granted summary judgment dismissing all claims; appellate court affirms, finding no actionable fiduciary breach or controlling-shareholder domination.
Delaware law governs; Rock’s standing and adequacy of evidence to show controlling influence were central to the appeal.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Whether Rock had standing to pursue a direct action for dilution.	Rock constant claims direct standing under Gentile.	Rangos/Meakem contend no controlling-shareholder status; damages belong to corporation.	Rock lacked actionable standing; business-judgment presumption applied.
Whether directors on both sides breached fiduciary duties in approving Term Sheet II.	Directors conflicted; entire fairness should apply.	Majority disinterested directors approved with §144 protections; entire-fairness not triggered.	No breach; business judgment rule applied; no entire-fairness breach proven.
Whether Rangos and Meakem were controlling shareholders who violated minority rights.	Rangos family controlling; manipulated terms to dilute Rock.	Insufficient evidence of actual control; no domination of board.	No controlling-shareholder liability; insufficient evidence of actual control.
Whether failure to disclose TI’s acquisition interest invalidated the board’s decision.	TI interest undisclosed disturbed fairness.	TI info known to board; no disclosure defect invalidating decision.	No disclosure defect sufficient to overturn board action.
Whether MBVC/Meakem’s roles tainted the process under §144 and fiduciary duties.	Misalignment and conflicts distorted process.	Section 144 protections applied; no independent committee required; no breach shown.	No breach; §144 analysis supports summary judgment.

Gentile v. Rossette, 906 A.2d 91 (Del. 2006) (direct action allowed when controlling-shareholder causes dilution at minority expense)
Tooley v. Donaldson, Lufkin & Jenrette, Inc., 845 A.2d 1081 (Del. 2004) (derivative action must be on behalf of corporation; recovery to corporation)
Weinberger v. UOP, Inc., 457 A.2d 701 (Del. 1983) (inside directors must show utmost good faith and fairness when on both sides)
Cinerama, Inc. v. Technicolor, Inc., 663 A.2d 1156 (Del. 1995) (entire fairness standard applies when conflicted directors control transaction)
Brehm v. Eisner, 746 A.2d 244 (Del. 2000) (burden shifts to show lack of business-judgment justification in derivative claims)
Aronson v. Lewis, 473 A.2d 805 (Del. 1984) (business judgment rule presumption; plaintiff must rebut with facts)